“It is early days yet, but our performance is only a pointer to our commitment to be a major player in the global pharma market. With a firm eye on the future, we have been taking all the strategic measures to ensure that we are at the right time at the right place to harvest the advantage when the markets cease to work to our advantage. I would say that there are some exciting days before us.”